THE ROLE OF ALPHA(1)-BLOCKADE IN BENIGN PROSTATIC HYPERPLASIA

被引：0
|
作者：
BRAWER, MK
机构：
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1993年 / 33卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：891 / 895
页数：5
相关论文
共 50 条
  • [41] alpha-blockers therapy in benign prostatic hyperplasia
    Jardin, A
    Andersson, KE
    Caine, M
    Chapple, C
    ElHilali, M
    Hertle, L
    Kawabe, K
    Kirby, R
    Lepor, H
    Pool, J
    3RD INTERNATIONAL CONSULTATION ON BPH, PROCEEDINGS 3, 1996, : 527 - &
  • [42] Alpha-blockers for the Treatment of Benign Prostatic Hyperplasia
    Lepor, Herbert
    UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (03) : 311 - +
  • [43] Alpha-blockade downregulates myosin heavy chain gene expression in human benign prostatic hyperplasia
    Lin, VK
    Benaim, EA
    McConnell, JD
    UROLOGY, 2001, 57 (01) : 170 - 175
  • [44] Alfuzosin (Uroxatral) -: Another alpha1-blocker for benign prostatic hyperplasia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2004, 46 (1173): : 1 - 2
  • [45] Glans hyperemia after penile revascularization: A late complication following alpha-1-receptor blockade for benign prostatic hyperplasia
    Haupt, G
    Pannek, J
    Pastor, J
    Schulze, H
    Senge, T
    UROLOGIA INTERNATIONALIS, 1997, 58 (01) : 61 - 63
  • [46] Benign prostatic hyperplasia
    Clarke, HS
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 314 (04): : 239 - 244
  • [47] Benign Prostatic Hyperplasia
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2024, 212 (06): : 924 - 926
  • [48] BENIGN PROSTATIC HYPERPLASIA
    HULBERT, JC
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 1989, 6 (01) : 8 - 9
  • [49] Benign prostatic hyperplasia
    Wilson, T
    BRITISH JOURNAL OF GENERAL PRACTICE, 1997, 47 (419): : 401 - 401
  • [50] Role of prostatic artery embolization in management of symptomatic benign prostatic hyperplasia
    Shaker, Mohamed
    Abd El Tawab, Karim A.
    Abd El Tawab, Khaled H.
    El-Gharib, Mohamed
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2016, 47 (03): : 839 - 845
12345